Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 116
Filter
Add more filters

Publication year range
1.
J Dairy Sci ; 107(7): 5029-5040, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38428494

ABSTRACT

We investigated the prevalence and spatial distribution of selected pathogens associated with infectious diseases of dairy cattle in Ontario, Canada. The cross-sectional study surveyed bulk tank milk for antibodies against bovine leukemia virus (BLV), Mycobacterium avium ssp. paratuberculosis (MAP), and Salmonella Dublin, and for the presence of mastitis pathogens (Staphylococcus aureus, Streptococcus agalactiae, Mycoplasma bovis). Between October 2021 and June 2022, bulk tank milk samples were obtained from every commercial dairy farm in Ontario (n = 3,286). Samples underwent ELISA testing for the presence of BLV, MAP, and S. Dublin antibodies, and quantitative PCR testing for the detection of specific antigens of pathogens associated with mastitis. Bayesian models were used to estimate prevalence, and spatial analysis was carried out to identify regional clusters of high pathogen prevalence. Prevalence varied for different pathogens, and BLV was widespread across dairy farms in Ontario, with an estimated prevalence of 88.3%. The prevalence of MAP, Staph. aureus and S. Dublin in Ontario dairy herds was 39.8%, 31.5%, and 5.1%, respectively. The vast majority of dairy herds in Ontario were free of intramammary infections caused by Strep. agalactiae and M. bovis. Clusters of increased positive test rates were detected for S. Dublin, MAP, and Staph. aureus, indicating potential geographic risk factors for pathogen transmission. For S. Dublin, an area of increased test positivity rates was detected in southwestern Ontario, close to the Canada-United States border where most of the dairy herds in Ontario are located. Conversely, a localized cluster of positive test outcomes involving 14 subdivisions located in the southeastern region of Ontario was detected for Staph. aureus. Findings from our survey highlight the importance of the testing of aggregated samples and conducting spatial analysis as part of disease surveillance programs, and for implementing risk-based trading approaches among dairy producers.


Subject(s)
Cattle Diseases , Milk , Animals , Cattle , Ontario/epidemiology , Prevalence , Female , Cross-Sectional Studies , Cattle Diseases/epidemiology , Cattle Diseases/microbiology , Milk/microbiology , Mastitis, Bovine/epidemiology , Mastitis, Bovine/microbiology , Staphylococcus aureus/isolation & purification , Communicable Diseases/veterinary , Communicable Diseases/epidemiology , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Dairying , Streptococcus agalactiae/isolation & purification
2.
J Dairy Sci ; 107(1): 476-488, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37709015

ABSTRACT

As clinical mastitis (CM) treatments are responsible for a large portion of antimicrobial use on dairy farms, many selective CM treatment protocols have been developed and evaluated against a blanket treatment approach of CM cases. Selective treatment protocols use outcomes of diagnostic tests to exclude CM cases from antimicrobial treatment when they are unlikely to benefit. To tailor interventions to increase uptake of selective treatment strategies, a comprehension of current on-farm treatment practices and factors affecting treatment decisions is vital. Two questionnaires were conducted among 142 farms across 5 provinces participating in the Canadian Dairy Network for Antimicrobial Stewardship and Resistance in this cross-sectional study. Self-reported adoption of selective CM treatments by dairy farmers was 64%, with median of 82% of cows treated in those herds using selective treatment. Using logistic regression models, the odds to implement a selective CM treatment protocol increased with a decreasing average cow somatic cell count. No other associations were identified between use of a selective CM treatment protocol and farm characteristics (herd size, CM incidence, province, milking system, and housing system). Three subsets of farmers making cow-level CM treatment decisions were identified using a cluster analysis approach: those who based decisions almost exclusively on severity of clinical signs, those who used various udder health indicators, and farmers who also incorporated more general cow information such as production, age, and genetics. When somatic cell count was considered, the median threshold used for treating was >300,000 cells/mL at the last Dairy Herd Improvement test. Various thresholds were present among those considering CM case history. Veterinary laboratories were most frequently used for bacteriological testing. Test results were used to start, change, and stop treatments. Regardless of protocol, reasons for antimicrobial treatment withheld included cow being on a cull list, having a chronic intramammary infection, or being at end of lactation (i.e., close to dry off). If clinical signs persisted after treatment, farmers indicated that they would ask veterinarians for advice, stop treatment, or continue with the same or different antibiotics. Results of this study can be used to design interventions targeting judicious mastitis-related antimicrobial use, and aid discussions between veterinarians and dairy producers regarding CM-related antimicrobial use.


Subject(s)
Anti-Infective Agents , Cattle Diseases , Mastitis, Bovine , Animals , Cattle , Female , Humans , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Canada , Cattle Diseases/drug therapy , Cell Count/veterinary , Cross-Sectional Studies , Dairying/methods , Farms , Mammary Glands, Animal , Mastitis, Bovine/drug therapy , Mastitis, Bovine/epidemiology , Milk
3.
J Dairy Sci ; 107(4): 2357-2373, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37863297

ABSTRACT

Salmonellosis is one of the leading causes of gastrointestinal infections in humans. In Canada, it is estimated that approximately 87,500 cases of salmonellosis occur every year in humans, resulting in 17 deaths. In the United States, it is estimated that 26,500 hospitalizations and 420 deaths occur every year. In dairy cattle, infections caused by nontyphoidal Salmonella enterica can cause mild to severe disease, including enteritis, pneumonia, and septicemia. Our study objectives were to determine the proportion of fecal samples positive for Salmonella in dairy cattle in Canada and determine the resistance pattern of these isolates. We used data collected through the Canadian Dairy Network for Antimicrobial Stewardship and Resistance (CaDNetASR). Pooled fecal samples from preweaning calves, postweaning heifers, lactating cows, and manure storage were cultured for Salmonella, and the isolates were identified using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Antimicrobial susceptibilities were determined using the minimum inhibitory concentration test, and resistance interpretation was made according to the Clinical and Laboratory Standards Institute. A 2-level, multivariable logistic regression model was built to determine the probability of recovering Salmonella from a sample, accounting for province, year, and sample source. The proportion of farms with at least one positive sample were 12% (17/140), 19% (28/144), and 17% (24/144) for the sampling years 2019, 2020, and 2021, respectively. Out of the 113 Salmonella isolates, 23 different serovars were identified. The occurrence of Salmonella appeared to be clustered by farms and provinces. The most common serovars identified were Infantis (14%) and Typhimurium (14%). Overall, 21% (24/113) of the Salmonella isolates were resistant to at least one antimicrobial. Resistance to tetracycline was commonly observed (17%); however, very limited resistance to category I antimicrobials (categorization according to Health Canada that includes third-generation cephalosporins, fluoroquinolones, polymyxins, and carbapenems) was observed, with one isolate resistant to amoxicillin and clavulanic acid. The proportion of Salmonella isolates resistant to 2 and 3 antimicrobial classes was 3.5% and 8.8%, respectively. Our study provided valuable information on the proportion of fecal samples positive for Salmonella, the serovars identified, and the associated resistance patterns across CaDNetASR herds, at regional and national levels.


Subject(s)
Anti-Infective Agents , Salmonella Infections, Animal , Salmonella enterica , Humans , Cattle , Animals , Female , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Lactation , Canada , Salmonella Infections, Animal/epidemiology , Dairying/methods , Feces , Salmonella , Anti-Infective Agents/pharmacology , Microbial Sensitivity Tests/veterinary , Drug Resistance, Multiple, Bacterial
4.
J Dairy Sci ; 106(3): 1986-2006, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36710183

ABSTRACT

Testing of bulk milk (BM) samples is a convenient, cost-effective strategy that can easily be implemented as part of disease surveillance programs on dairy farms. Here, we performed a scoping review to summarize the literature reporting on the testing of BM samples to detect infectious diseases of dairy cattle caused by bacteria. We also provide a non-exhaustive, albeit significant, list of diagnostic tests that are marketed for BM samples, as well as a list of disease surveillance activities that included testing of BM samples. A literature search was carried out in 5 databases, yielding 8,829 records from which 474 were retained. Overall, 575 eligible bacterial pathogens were screened for using BM samples, ranging from 1 to 6 individual pathogens per study. Staphylococcus aureus, including methicillin-resistant Staph. aureus, were the most studied bacteria (n = 179 studies), followed by Streptococcus agalactiae (86), Mycobacterium avium ssp. paratuberculosis (79), Coxiella burnetii (79), and Mycoplasma spp. (67). Overall, culture-based protocols, ELISA, real-time PCR, and PCR were the most commonly adopted methodologies to screen BM samples. Sensitivity of BM testing for bovine paratuberculosis was generally low and varied greatly according to the ELISA cut-offs adopted and herd-level definition of disease. In general, protocols had low to moderate sensitivities (<50%), which increased for herds with high within-herd seroprevalence. Specificity of BM testing for paratuberculosis was generally high. With respect to mastitis pathogens, BM testing demonstrated high sensitivity and specificity for Strep. agalactiae, in general. However, we observed inconsistency among studies with respect to the sensitivity of BM culture to detect infected herds, which was notably higher if enrolled herds were heavily infected or had history of clinical disease. Among Salmonella spp. pathogens, Salmonella Dublin was the most frequently studied bacterium for which BM testing has been validated. Specificity of BM ELISA was high, ranging from 89.0 to 99.4. In contrast, sensitivity varied greatly among studies, ranging from 50.6% to 100%. Our findings support that one of most important factors affecting sensitivity of BM ELISA for Salmonella Dublin is whether nonlactating cattle are considered in the definition of herd infection status. In general, protocols analyzed in this review suffered from very low sensitivities, which hardly justifies their use as part of disease surveillance as single testing. Nevertheless, test sensitivity can be increased by the adoption of more inclusive definitions of disease-free herds. Further, low-sensitivity and high-specificity methods can be valuable tools for surveillance when used repeatedly over time.


Subject(s)
Cattle Diseases , Communicable Diseases , Mycobacterium avium subsp. paratuberculosis , Paratuberculosis , Female , Cattle , Animals , Paratuberculosis/microbiology , Milk/microbiology , Seroepidemiologic Studies , Cattle Diseases/epidemiology , Sensitivity and Specificity , Communicable Diseases/veterinary , Real-Time Polymerase Chain Reaction/veterinary , Enzyme-Linked Immunosorbent Assay/veterinary , Staphylococcus aureus , Streptococcus agalactiae
5.
J Dairy Sci ; 106(8): 5636-5658, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37291033

ABSTRACT

In this scoping review, we characterized the literature reporting on the testing of bulk milk samples to detect microorganisms other than bacteria that can cause diseases in dairy cattle, including viruses, helminths, algae, and protozoa. A search strategy was completed by screening databases, conference proceedings, animal health agency websites, disease surveillance program websites, and handbooks of cattle-related diagnostic tests for potentially relevant articles. Two reviewers independently screened articles in English, Portuguese, or Spanish; original studies reporting on the testing of farm-level, unprocessed bulk milk samples for presence of pathogens or specific antibodies against agents other than bacteria that can cause diseases in cows were retained. From all studies, we used spreadsheets to extract relevant information, including pathogen screened, test used, and country of origin of bulk milk samples. Additionally, for studies reporting sufficient data to estimate test characteristics, we extracted detailed information about herd eligibility, testing protocol, and herd-level infection definition. A total of 8,829 records were identified, from which 1,592 were retained and assessed for eligibility, and 306 were included. Bovine viral diarrhea virus, Fasciola hepatica, Ostertagia ostertagi, and bovine herpesvirus 1 were the most frequently screened agents, reported from 107, 45, 45, and 33 studies, respectively. Sensitivity of bulk milk ELISA to detect herds with animals infected by bovine herpesvirus 1 ranged from 2 to 100%, and was affected mostly by antigen selection, cut-off adopted, herd vaccination status, and seroprevalence of lactating cows. Bulk milk ELISA had very high specificity to detect herds free of bovine leukemia virus, and varying sensitivity to detect herds with infected animals, which depended on the within-herd seroprevalence of lactating cattle. As for bovine viral diarrhea virus, in general, the sensitivity of bulk milk ELISA was moderate to high (>80%) when infection status was defined based on presence of persistently infected cattle or a high proportion of seropositive lactating cattle. Nevertheless, bulk milk ELISA was not able to distinguish infected and noninfected herds based on presence of seropositive unvaccinated weanlings. The PCR or quantitative PCR protocols employed had very low sensitivities (<40%) and very high specificities (>95%) to classify bovine viral diarrhea virus infection status of dairy herds. Sensitivity and specificity of bulk milk ELISA to classify herds with regards to presence of F. hepatica- or O. ostertagi-parasitized cattle were generally high and driven mostly by the definition of herd infection status. Conversely, bulk milk ELISA demonstrated varying characteristics to detect herds with or without Dictyocaulus viviparus-parasitized cattle, depending primarily on the antigen selected and presence of cattle with clinical signs of lungworm infection.


Subject(s)
Cattle Diseases , Herpesvirus 1, Bovine , Female , Cattle , Animals , Milk , Lactation , Seroepidemiologic Studies , Cattle Diseases/epidemiology , Enzyme-Linked Immunosorbent Assay/veterinary , Diarrhea/veterinary
6.
J Dairy Sci ; 106(1): 302-311, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36333137

ABSTRACT

The removal (culling) of dairy cows from the farm is a regular and required management practice. The main objectives of this study were to describe the involvement of bovine veterinarians in Ontario, Canada, in dairy cull cow management decisions, their expectations of current producer practices, and their perspectives on welfare issues and best management practices for cull dairy cows. Between February and May 2021, a province-wide survey was conducted among all members of the Ontario Association of Bovine Practitioners (OABP), with questions addressing veterinarians' background and demographics, veterinary clinic characteristics, cull cow management, down cow management, and learning preferences. The response rate for the survey was 25.1%, with 45 responses meeting all eligibility criteria. Dairy veterinarians would like to have greater involvement in cull cow management; when asked for desired involvement in culling decisions, 57.5% of veterinarians would like to be involved in culling decisions most of the time or always. Most (70.0%) veterinarians believed that cull cow welfare has improved over the last decade. However, most respondents also identified at least one area of management (farm of origin, transportation, auction, slaughter) as currently being a high risk to cull cow welfare. Given the frequency of their visits, trust by dairy producers, and knowledge, herd veterinarians are among those in the best position to improve the care of cull dairy cows. Information generated from this survey can be used to inform the development of improved decision-making tools for culling cows, and this, along with increased veterinarians' involvement in cull cow management, could improve the economic and welfare outcomes of culling decisions for dairy producers.


Subject(s)
Dairying , Veterinarians , Female , Cattle , Animals , Humans , Ontario , Attitude , Surveys and Questionnaires
7.
J Dairy Sci ; 106(10): 7104-7116, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37500435

ABSTRACT

Infections with antimicrobial resistant pathogens are a major threat to human and animal health worldwide. Further, reduction of livestock-associated antimicrobial use (AMU) is often identified as an area of focus. Selective dry cow therapy (DCT) warrants consideration as an important way to decrease AMU on Canadian dairy farms. In addition, teat sealants (TS) are a nonantimicrobial alternative for prevention of intramammary infection during the dry period. Therefore, objectives of this study were to determine how antimicrobials and TS are used at dry-off on Canadian dairy farms to determine selective DCT uptake and enacted selection protocols. It was expected that these data will provide a baseline understanding of DCT practices and highlight areas for future intervention to further reduce AMU. An observational study was conducted utilizing 2 in-person questionnaires conducted between July 2019 and September 2021 on 144 participating dairy farms in 5 Canadian provinces (British Columbia = 30, Alberta = 30, Ontario = 31, Québec = 29, and Nova Scotia = 24). Overall, 45 farms (31%) reported adopting selective DCT, 95 (66%) enacted blanket DCT, and 4 (3%) did not provide antimicrobial DCT. Farms enacting selective DCT had approximately 50% less intramammary antimicrobials used at dry-off compared with blanket DCT farms. Cow somatic cell count history was the most common criterion for selective DCT decision-making, followed by previous clinical mastitis history, bacteriological culture, and milk production. A slight majority of farms (56%) applied TS to all cows at dry-off, whereas 17 farms (12%) used TS selectively, and 46 farms (32%) did not use TS. Larger herds more often used TS, and farms with an automatic milking system more often used TS selectively than applied to all cows. Results highlighted the variability in antimicrobial treatment and TS use protocols at dry-off on Canadian dairy farms, and the potential for further antimicrobial reduction with increased adoption of selective DCT.


Subject(s)
Anti-Infective Agents , Mastitis, Bovine , Female , Animals , Cattle , Humans , Farms , Patient Selection , Mastitis, Bovine/prevention & control , Mastitis, Bovine/drug therapy , Anti-Infective Agents/therapeutic use , Milk , Ontario , Mammary Glands, Animal , Cell Count/veterinary , Anti-Bacterial Agents/therapeutic use , Lactation , Dairying/methods
8.
J Dairy Sci ; 106(6): 3761-3778, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37080782

ABSTRACT

Treatment of clinical mastitis (CM) and use of antimicrobials for dry cow therapy are responsible for the majority of animal-defined daily doses of antimicrobial use (AMU) on dairy farms. However, advancements made in the last decade have enabled excluding nonsevere CM cases from antimicrobial treatment that have a high probability of cure without antimicrobials (no bacterial causes or gram-negative, excluding Klebsiella spp.) and cases with a low bacteriological cure rate (chronic cases). These advancements include availability of rapid diagnostic tests and improved udder health management practices, which reduced the incidence and infection pressure of contagious CM pathogens. This review informed an evidence-based protocol for selective CM treatment decisions based on a combination of rapid diagnostic test results, review of somatic cell count and CM records, and elucidated consequences in terms of udder health, AMU, and farm economics. Relatively fast identification of the causative agent is the most important factor in selective CM treatment protocols. Many reported studies did not indicate detrimental udder health consequences (e.g., reduced clinical or bacteriological cures, increased somatic cell count, increased culling rate, or increased recurrence of CM later in lactation) after initiating selective CM treatment protocols using on-farm testing. The magnitude of AMU reduction following a selective CM treatment protocol implementation depended on the causal pathogen distribution and protocol characteristics. Uptake of selective treatment of nonsevere CM cases differs across regions and is dependent on management systems and adoption of udder health programs. No economic losses or animal welfare issues are expected when adopting a selective versus blanket CM treatment protocol. Therefore, selective CM treatment of nonsevere cases can be a practical tool to aid AMU reduction on dairy farms.


Subject(s)
Anti-Infective Agents , Cattle Diseases , Mastitis, Bovine , Female , Cattle , Animals , Milk/microbiology , Mastitis, Bovine/microbiology , Anti-Infective Agents/therapeutic use , Lactation , Mammary Glands, Animal/microbiology , Cell Count/veterinary , Anti-Bacterial Agents/therapeutic use , Cattle Diseases/drug therapy
9.
J Dairy Sci ; 106(2): 1267-1286, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36543640

ABSTRACT

Treatment of clinical mastitis (CM) contributes to antimicrobial use on dairy farms. Selective treatment of CM based on bacterial diagnosis can reduce antimicrobial use, as not all cases of CM will benefit from antimicrobial treatment, e.g., mild and moderate gram-negative infections. However, impacts of selective CM treatment on udder health and culling are not fully understood. A systematic search identified 13 studies that compared selective versus blanket CM treatment protocols. Reported outcomes were synthesized with random-effects models and presented as risk ratios or mean differences. Selective CM treatment protocol was not inferior to blanket CM treatment protocol for the outcome bacteriological cure. Noninferiority margins could not be established for the outcomes clinical cure, new intramammary infection, somatic cell count, milk yield, recurrence, or culling. However, no differences were detected between selective and blanket CM treatment protocols using traditional analyses, apart from a not clinically relevant increase in interval from treatment to clinical cure (0.4 d) in the selective group and higher proportion of clinical cure at 14 d in the selective group. The latter occurred in studies co-administering nonsteroidal anti-inflammatories only in the selective group. Bias could not be ruled out in most studies due to suboptimal randomization, although this would likely only affect subjective outcomes such as clinical cure. Hence, findings were supported by a high or moderate certainty of evidence for all outcome measures except clinical cure. In conclusion, this review supported the assertion that a selective CM treatment protocol can be adopted without adversely influencing bacteriological and clinical cure, somatic cell count, milk yield, and incidence of recurrence or culling.


Subject(s)
Anti-Infective Agents , Cattle Diseases , Mastitis, Bovine , Cattle , Female , Animals , Milk/microbiology , Anti-Bacterial Agents/therapeutic use , Mastitis, Bovine/drug therapy , Mastitis, Bovine/microbiology , Anti-Infective Agents/therapeutic use , Cell Count/veterinary , Mammary Glands, Animal/microbiology , Lactation , Cattle Diseases/drug therapy
10.
J Dairy Sci ; 105(9): 7161-7189, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35931474

ABSTRACT

Administering intramammary antimicrobials to all mammary quarters of dairy cows at drying-off [i.e., blanket dry cow therapy (BDCT)] has been a mainstay of mastitis prevention and control. However, as udder health has considerably improved over recent decades with reductions in intramammary infection prevalence at drying-off and the introduction of teat sealants, BDCT may no longer be necessary on all dairy farms, thereby supporting antimicrobial stewardship efforts. This narrative review summarizes available literature regarding current dry cow therapy practices and associated impacts of selective dry cow therapy (SDCT) on udder health, milk production, economics, antimicrobial use, and antimicrobial resistance. Various methods to identify infections at drying-off that could benefit from antimicrobial treatment are described for selecting cows or mammary quarters for treatment, including utilizing somatic cell count thresholds, pathogen identification, previous clinical mastitis history, or a combination of criteria. Selection methods may be enacted at the herd, cow, or quarter levels. Producers' and veterinarians' motivations for antimicrobial use are discussed. Based on review findings, SDCT can be adopted without negative consequences for udder health and milk production, and concurrent teat sealant use is recommended, especially in udder quarters receiving no intramammary antimicrobials. Furthermore, herd selection should be considered for SDCT implementation in addition to cow or quarter selection, as BDCT may still be temporarily necessary in some herds for optimal mastitis control. Costs and benefits of SDCT vary among herds, whereas impacts on antimicrobial resistance remain unclear. In summary, SDCT is a viable management option for maintaining udder health and milk production while improving antimicrobial stewardship in the dairy industry.


Subject(s)
Anti-Infective Agents , Cattle Diseases , Mastitis, Bovine , Animals , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Cattle , Cattle Diseases/drug therapy , Cell Count/veterinary , Dairying , Female , Lactation , Mammary Glands, Animal , Mastitis, Bovine/drug therapy , Mastitis, Bovine/epidemiology , Mastitis, Bovine/prevention & control , Milk
11.
Can Vet J ; 63(3): 297-300, 2022 03.
Article in English | MEDLINE | ID: mdl-35237018

ABSTRACT

The objective of this cross-sectional study was to evaluate the presence of infectious disease in newly arrived cattle on dairy farms in Ontario. Cattle that were more than 2 years old and arrived at dairy farms within the previous year were tested. A total 321 cattle from 56 dairy farms were sampled and had blood submitted to a diagnostic laboratory. Of all sampled cattle, 0.0%, 39.6%, 2.2%, and 1.3% tested positive for Anaplasma, bovine leukemia virus, Mycobacterium avium subsp. paratuberculosis, and Salmonella Dublin, respectively. Based on these results, it is imperative that dairy producers are vigilant to ensure they do not purchase animals with these important and untreatable infectious diseases.


Acheteur prenez garde! Dépistage des maladies des bovins nouvellement arrivés dans les fermes laitières de l'Ontario. L'objectif de cette étude transversale était d'évaluer la présence de maladies infectieuses chez les bovins nouvellement arrivés dans les fermes laitières de l'Ontario. Les bovins âgés de plus de 2 ans et arrivés dans les fermes laitières au cours de l'année précédente ont été testés. Au total, 321 bovins provenant de 56 fermes laitières ont été échantillonnés et leur sang a été soumis à un laboratoire de diagnostic. De tous les bovins échantillonnés, 0,0 %, 39,6 %, 2,2 % et 1,3 % ont été testés positifs pour Anaplasma, le virus de la leucémie bovine, Mycobacterium avium subsp. paratuberculosis et Salmonella Dublin, respectivement. Sur la base de ces résultats, il est impératif que les producteurs laitiers soient vigilants pour s'assurer qu'ils n'achètent pas d'animaux atteints de ces maladies infectieuses importantes et incurables.(Traduit par Dr Serge Messier).


Subject(s)
Cattle Diseases , Mycobacterium avium subsp. paratuberculosis , Paratuberculosis , Animals , Cattle , Cattle Diseases/diagnosis , Cattle Diseases/epidemiology , Cattle Diseases/microbiology , Cross-Sectional Studies , Farms , Ontario/epidemiology , Paratuberculosis/diagnosis , Paratuberculosis/epidemiology , Paratuberculosis/microbiology , Prevalence
12.
Can Vet J ; 63(3): 260-268, 2022 03.
Article in English | MEDLINE | ID: mdl-35237012

ABSTRACT

The objectives of this study were to i) describe Escherichia coli and Salmonella isolates; ii) investigate the temporal trends in antimicrobial resistance (AMR) profiles; and iii) evaluate the impact of season and age on these AMR profiles from diagnostic and post-mortem samples in Ontario calves ≤ 2-months-old submitted from 2007 to 2020 to the Animal Health Laboratory in Guelph, Ontario, Canada. Antimicrobial susceptibility testing results were measured by the Kirby-Bauer disk diffusion method. A total of 1291 isolates with AMR profiles were obtained from calves, with E. coli (n = 434) and Salmonella (n = 378) being the most common bacteria characterized for AMR. For E. coli, 79% of isolates tested showed a positive result in F5/K99, whereas for Salmonella isolates, S. Typhimurium (33%) and S. Dublin (22%) were the 2 most common serotypes identified. Multivariable logistic regression models were built to evaluate AMR profiles for E. coli (n = 414) and Salmonella (n = 357) to each antimicrobial tested. Most E. coli isolates (91%) and Salmonella isolates (97%) were resistant to at least one of the antimicrobials tested. In general, E. coli and Salmonella had higher odds of resistance in calves aged ≥ 2 wk compared to 1-week-old calves, and little difference was seen in the level of resistance over the years observed or between seasons in most of the antimicrobials tested. Prospective research should investigate potential risk factors for the development of AMR in calves examples being antimicrobial use and farm management practices.


Étude observationnelle sur la résistance aux antimicrobiens d'isolats d'Escherichia coli et de Salmonella provenant d'échantillons de veaux de l'Ontario soumis à un laboratoire de diagnostic de 2007 à 2020. Les objectifs de cette étude étaient de i) décrire les isolats d'Escherichia coli et de Salmonella; ii) étudier les tendances temporelles des profils de résistance aux antimicrobiens (RAM); et iii) évaluer l'impact de la saison et de l'âge sur ces profils de RAM à partir d'échantillons diagnostiques et post-mortem de veaux de l'Ontario âgés de ≤ 2 mois soumis de 2007 à 2020 au Laboratoire de santé animale de Guelph, Ontario, Canada. Les résultats des tests de sensibilité aux antimicrobiens ont été mesurés par la méthode de diffusion en disque de Kirby-Bauer. Un total de 1291 isolats avec des profils de RAM ont été obtenus à partir de veaux, E. coli (n = 434) et Salmonella (n = 378) étant les bactéries les plus courantes caractérisées pour la RAM. Pour E. coli, 79 % des isolats testés ont montré un résultat positif en F5/K99, alors que pour les isolats de Salmonella, S. Typhimurium (33 %) et S. Dublin (22 %) étaient les deux sérotypes les plus fréquemment identifiés. Des modèles de régression logistique multivariable ont été construits pour évaluer les profils de RAM pour E. coli (n = 414) et Salmonella (n = 357) pour chaque antimicrobien testé. La plupart des isolats d'E. coli (91 %) et des isolats de Salmonella (97 %) étaient résistants à au moins un des antimicrobiens testés. En général, E. coli et Salmonella présentaient un risque de résistance plus élevé chez les veaux âgés de ≥ 2 semaines par rapport aux veaux âgés d'une semaine, et peu de différence a été observée dans le niveau de résistance au cours des années observées ou entre les saisons pour la plupart des antimicrobiens testés. La recherche prospective devrait étudier les facteurs de risque potentiels pour le développement de la RAM chez les veaux, par exemple l'utilisation d'antimicrobiens et les pratiques de gestion de la ferme.(Traduit par Dr Serge Messier).


Subject(s)
Cattle Diseases , Escherichia coli Infections , Animals , Anti-Bacterial Agents/pharmacology , Cattle , Cattle Diseases/epidemiology , Drug Resistance, Bacterial , Escherichia coli , Escherichia coli Infections/drug therapy , Escherichia coli Infections/epidemiology , Escherichia coli Infections/veterinary , Feces/microbiology , Microbial Sensitivity Tests/veterinary , Ontario/epidemiology , Prospective Studies , Salmonella
13.
J Dairy Sci ; 104(7): 7996-8008, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33896644

ABSTRACT

Regular veterinary visits to improve herd health and production management (HHPM) are important management components on many dairy cattle farms. These visits provide opportunities for constructive conversations between veterinarians and farmers and for shifting management from a reactionary approach to proactively optimizing health and welfare. However, little is known about the structure of HHPM farm visits and to what extent veterinarians provide assistance beyond purely technical services. Therefore, our aims in this cross-sectional study were to describe HHPM farm visit structure, determine which dairy-specific topics were discussed, and assess whether the focus of the visits aligned with farmers' priorities. Veterinary practitioners (n = 14) were recruited to record audio and video of regularly scheduled HHPM farm visits (n = 70) using an action camera attached to their chest or head. A questionnaire was distributed to farmers containing closed- and open-ended questions to assess their goals and perceptions related to farm management and HHPM farm visits. Descriptive statistics and negative binomial and Poisson regression models were used to study dairy-specific topics initiated by the farmer or veterinarian during various activities. A mean of 51% of the visit duration was dedicated to transrectal pregnancy and fertility diagnostics, and a considerable amount of time (30%) was spent on visit preparation, transitions between tasks, and leaving. A total of 488 discussions were initiated by either the veterinarian (55%) or the farmer (45%). Mean length of discussions was 2 min, and only 17% of the HHPM visit duration was spent discussing dairy-specific topics. Veterinarians initiated 62% of their discussions about herd issues, whereas farmer-initiated discussions revolved around herd health in 39% of the discussions. Discussion topics most frequently raised by participants included fertility, udder health, calf health and management, and transition diseases. Consistently, farmers' answers to a rank question regarding their main HHPM farm visit goals indicated that their priorities were to have transrectal pregnancy and fertility diagnostics performed and to improve herd fertility and general herd health. Answers to an open-ended question revealed that additional aims of many farmers were to receive information, have questions answered, and identify and discuss problems. A farmer's belief that HHPM farm visits were "absolutely" tailored toward his or her goals was positively associated with number of discussions during the visit and their conviction that they "always" voiced their wishes and needs to the veterinarian. Opportunities to broaden the focus of HHPM farm visits and improve communication between farmers and veterinarians should be identified and veterinarians should be trained accordingly, which would increase veterinarians' ability to add value during HHPM farm visits.


Subject(s)
Dairying , Veterinarians , Animals , Canada , Cattle , Cross-Sectional Studies , Farmers , Farms , Female , Goals
14.
J Dairy Sci ; 104(9): 10143-10157, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34099288

ABSTRACT

The objective of this scoping review was to characterize all available literature on modifiable management practices used during the dry period that have been evaluated for their effects on udder health in dairy cattle during the dry period and the subsequent lactation. Five databases and two conference proceedings were searched for relevant literature. Articles published in or after 1990 were eligible for inclusion. Eligible interventions or exposures were restricted to modifiable management practices; however, antimicrobial and teat sealant products were enumerated but not further characterized, as systematic reviews have been published on this topic. Other modifiable management practices were reported in 229 articles. Nutrition (n = 79), which included ration formulation and delivery (n = 44) and vitamin and mineral additives (n = 35), was the most commonly reported practice, followed by vaccines (n = 40) and modification of dry period length (n = 27). Risk of clinical mastitis (CM) was the most commonly reported outcome (n = 151); however, reporting of outcome risk periods varied widely between articles. Cure of existing intramammary infections (IMI) over the dry period (n = 40) and prevention of new IMI over the dry period (n = 54) were most commonly reported with a risk period between calving and 30 d in milk. Future systematic reviews with meta-analyses could target management practices such as nutrition, vaccines, and dry period length to quantify their effects on improving udder health during the dry period and early lactation. However, the variation in reporting of time at risk for CM and other outcomes challenges the ability of future synthesis work to inform management decisions on the basis of efficacy to cure or prevent IMI and CM. Consensus on which core outcomes should be evaluated in mastitis research and the selection of consistent risk periods for specific outcomes in animal trials is imperative.


Subject(s)
Cattle Diseases , Mastitis, Bovine , Animals , Anti-Bacterial Agents/therapeutic use , Cattle , Cattle Diseases/drug therapy , Cell Count/veterinary , Female , Lactation , Mammary Glands, Animal , Mastitis, Bovine/drug therapy , Mastitis, Bovine/prevention & control , Milk
15.
J Dairy Sci ; 104(9): 10100-10110, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34099297

ABSTRACT

The objective of this randomized, double-blind, controlled trial was to evaluate the effect of pegbovigrastim (pegylated recombinant bovine granulocyte colony-stimulating factor) on early-lactation disease, milk yield, and reproduction on commercial dairy farms. A total of 1,607 Holstein cows from 6 farms in Ontario and Québec, Canada, were randomly assigned to receive two 2.7-mL subcutaneous injections of either 15 mg of pegbovigrastim (n = 798; Imrestor, Elanco) or sterile physiological saline (placebo; n = 809). The first injection was administered by investigators 1 wk before expected calving, and the second by farm personnel within 24 h after calving, according to the product label. Producers inspected cows daily and using standardized disease definitions, recorded cases of retained placenta, metritis, displaced abomasum, and clinical mastitis until 63 d in milk. Progesterone concentration was measured in serum at wk 3, 5, 7, and 9 postpartum. Cows were examined for purulent vaginal discharge using the Metricheck (Simcro) device and endometritis using the cytobrush method at wk 5 postpartum. Milk production and reproduction data were obtained from farm management software and the national milk recording database. Disease and culling outcomes were assessed with logistic regression, milk production with linear regression, and time-to-event outcomes with proportional hazards regression. All analyses considered parity and pre-treatment body condition score and their interaction with treatment, and accounted for clustering of cows within farm. In a subset of 246 cows, the effect of treatment on metabolic markers (serum concentrations of glucose, ß-hydroxybutyrate, nonesterified fatty acids, cholesterol, haptoglobin, albumin, and calcium) was assessed in wk 1 and 2 postpartum. Pegbovigrastim had no significant effects on the incidence of retained placenta, metritis, displaced abomasum, clinical or subclinical mastitis, purulent vaginal discharge, or endometritis. Treatment reduced the serum concentration of glucose, slightly reduced the concentration of albumin, and slightly increased concentrations of ß-hydroxybutyrate and nonesterified fatty acids, with no effect on the other markers. There were no differences between treatments in culling risk, time to first insemination, pregnancy at first insemination, or time to pregnancy. Milk yield over the first 3 test days of lactation was 1.0 kg per day lower in the pegbovigrastim group, although a mechanism for that effect could not be explained through analysis of our data.


Subject(s)
Cattle Diseases , Lactation Disorders , Lactation , Animals , Cattle , Female , Granulocyte Colony-Stimulating Factor , Lactation Disorders/veterinary , Milk , Ontario , Postpartum Period , Pregnancy , Recombinant Proteins , Reproduction
16.
J Dairy Sci ; 104(10): 11317-11332, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34304877

ABSTRACT

Current sensor systems are used to detect cows with clinical mastitis. Although, the systems perform well enough to not negatively affect the adoption of automatic milking systems, the performance is far from perfect. An important advantage of sensor systems is the availability of multiple measurements per day. By clearly defining the need for detection of subclinical mastitis (SCM) and clinical mastitis (CM) from the farmers' management perspective, detection and management of SCM and CM may be improved. Sensor systems may also be used for other aspects of mastitis management. In this paper we have defined 4 mastitis situations that could be managed with the support of sensor systems. Because of differences in the associated management and the epidemiology of these specific mastitis situations, the required demands for performance of the sensor systems do differ. The 4 defined mastitis situations with the requirements of performance are the following: (1) Cows with severe CM needing immediate attention. Sensor systems should have a very high sensitivity (>95% and preferably close to 100%) and specificity (>99%) within a narrow time window (maximum 12 h) to ensure that close to all cows with true cases of severe CM are detected quickly. Although never studied, it is expected that because of the effects of severe CM, such a high detection performance is feasible. (2) Cows with mastitis that do not need immediate attention. Although these cows have a risk of progressing into severe CM or chronic mastitis, they should get the chance to cure spontaneously under close monitoring. Sensor alerts should have a reasonable sensitivity (>80%) and a high specificity (>99.5%). The time window may be around 7 d. (3) Cows needing attention at drying off. For selective dry cow treatment, the absence or presence of an intramammary infection at dry-off needs to be known. To avoid both false-positive and false-negative alerts, sensitivity and specificity can be equally high (>95%). (4) Herd-level udder health. By combining sensor readings from all cows in the herd, novel herd-level key performance indicators can be developed to monitor udder health status and development over time and raise alerts at significant deviances from predefined thresholds; sensitivity should be reasonably high, >80%, and because of the costs for further analysis of false-positive alerts, the specificity should be >99%. The development and validation of sensor-based algorithms specifically for these 4 mastitis situations will encourage situation-specific farmer interventions and operational udder health management.


Subject(s)
Cattle Diseases , Escherichia coli Infections , Mastitis, Bovine , Mastitis , Animals , Cattle , Cell Count/veterinary , Dairying , Escherichia coli Infections/veterinary , Female , Mammary Glands, Animal , Mastitis/veterinary , Mastitis, Bovine/diagnosis , Milk
17.
Stroke ; 51(4): 1158-1165, 2020 04.
Article in English | MEDLINE | ID: mdl-32126938

ABSTRACT

Background and Purpose- Little is known about the association between covert vascular brain injury and cognitive impairment in middle-aged populations. We investigated if scores on a cognitive screen were lower in individuals with higher cardiovascular risk, and those with covert vascular brain injury. Methods- Seven thousand five hundred forty-seven adults, aged 35 to 69 years, free of cardiovascular disease underwent a cognitive assessment using the Digital Symbol Substitution test and Montreal Cognitive Assessment, and magnetic resonance imaging (MRI) to detect covert vascular brain injury (high white matter hyperintensities, lacunar, and nonlacunar brain infarctions). Cardiovascular risk factors were quantified using the INTERHEART (A Global Study of Risk Factors for Acute Myocardial Infarction) risk score. Multivariable mixed models tested for independent determinants of reduced cognitive scores. The population attributable risk of risk factors and MRI vascular brain injury on low cognitive scores was calculated. Results- The mean age of participants was 58 (SD, 9) years; 55% were women. Montreal Cognitive Assessment and Digital Symbol Substitution test scores decreased significantly with increasing age (P<0.0001), INTERHEART risk score (P<0.0001), and among individuals with high white matter hyperintensities, nonlacunar brain infarction, and individuals with 3+ silent brain infarctions. Adjusted for age, sex, education, ethnicity covariates, Digital Symbol Substitution test was significantly lowered by 1.0 (95% CI, -1.3 to -0.7) point per 5-point cardiovascular risk score increase, 1.9 (95% CI, -3.2 to -0.6) per high white matter hyperintensities, 3.5 (95% CI, -6.4 to -0.7) per nonlacunar stroke, and 6.8 (95% CI, -11.5 to -2.2) when 3+ silent brain infarctions were present. No postsecondary education accounted for 15% (95% CI, 12-17), moderate and high levels of cardiovascular risk factors accounted for 19% (95% CI, 8-30), and MRI vascular brain injury accounted for 10% (95% CI, -3 to 22) of low test scores. Conclusions- Among a middle-aged community-dwelling population, scores on a cognitive screen were lower in individuals with higher cardiovascular risk factors or MRI vascular brain injury. Much of the population attributable risk of low cognitive scores can be attributed to lower educational attainment, higher cardiovascular risk factors, and MRI vascular brain injury.


Subject(s)
Brain Injuries/diagnostic imaging , Brain Injuries/psychology , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/psychology , Magnetic Resonance Imaging/trends , Mental Status and Dementia Tests , Adult , Aged , Brain Injuries/complications , Cognitive Dysfunction/etiology , Cohort Studies , Female , Humans , Male , Middle Aged , Prospective Studies
18.
J Dairy Sci ; 103(12): 11008-11024, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33222845

ABSTRACT

In its simplest form, longevity is defined as the ability to live a long life. Within the dairy industry, longevity has been defined and measured in many different ways, and the aim of this review is to disentangle the definitions and provide some clarity. Using a more standardized approach for defining and measuring longevity, both in academic discussions and on-farm application, we suggest using herd life (days) for time from birth until culling, and length of productive life (days) for time from first calving until culling. Despite identified benefits of extending the length of productive life, global trends in the time spent by dairy cattle in the herd have mostly been negative. Factors influencing herd life, such as health, rearing, environmental conditions, and management, are often ignored when longevity goals are evaluated, thereby underestimating the effect these factors have on defining overall longevity. Also, production efficiency, herd profitability, and welfare are not necessarily served by the longest life but rather by the optimized length of herd life instead. The majority of research has focused on the role of genetics on longevity. In this review, we provide insight into influences affecting dairy cow herd life as well as farm- and cow-level factors associated herewith. Finally, we suggest using herd life, including reproduction, production, health, and youngstock performance, for farm-level evaluation and length of productive life for time spent in the lactating herd.


Subject(s)
Cattle/physiology , Longevity/physiology , Animals , Dairying/economics , Dairying/methods , Farms , Female , Health Status , Lactation , Reproduction
19.
Can Vet J ; 61(10): 1065-1072, 2020 10.
Article in English | MEDLINE | ID: mdl-33012822

ABSTRACT

Data generated from Statistics Canada's 2016 Census of Agriculture and Census of Population were used to describe the adoption of 8 technologies by the Canadian dairy industry: computer/laptop, smartphone/tablet, auto-steering, auto-feeding, auto-environment, robotic milking, global positioning systems (GPS), and geographical information systems (GIS). Logistic regression was used to analyze the adoption of each technology by geographical region, operators' gender, operators' age, herd size, and number of operators per farm. Gender and age were marginally related to the level of adoption of each technology, whereas the number of operators per dairy farm and farm size were associated with increased adoption of most technologies. Quebec had the smallest average farm size, but the highest levels of adoption for 5 of 8 technologies.


Facteurs associés avec l'adoption des technologies par l'industrie laitière canadienne. Les données générées par le Recensement de la population et le Recensement de l'agriculture de 2016 de Statistiques Canada furent utilisées pour décrire l'adoption de huit technologies par l'industrie laitière canadienne : ordinateur/portable, téléphone intelligent/tablette, assistant à la navigation, alimentation automatique, environnement automatisé, traite robotisée, système de positionnement global (GPS), et système d'information géographique (GIS). Une régression logistique fut utilisée pour analyser l'adoption de chaque technologie par région géographique, sexe de l'opérateur, l'âge de l'opérateur, taille du troupeau, et nombre d'opérateurs par ferme. Le sexe et l'âge étaient reliés de manière marginale au degré d'adoption de chaque technologie, alors que le nombre d'opérateurs par ferme et la taille de la ferme étaient associés avec une augmentation de l'adoption de la plupart des technologies. Le Québec avait la taille moyenne des fermes la plus petite, mais le niveau d'adoption le plus élevé pour cinq des huit technologies.(Traduit par Dr Serge Messier).


Subject(s)
Dairying , Milk , Animals , Canada , Quebec , Technology
20.
Can Vet J ; 61(7): 757-762, 2020 07.
Article in English | MEDLINE | ID: mdl-32655160

ABSTRACT

As part of the ProAction on-farm program to implement national biosecurity requirements on dairy farms, Canadian veterinarians are called upon to complete biosecurity risk assessments. The objective of the present study was consequently to understand veterinarians' perceptions of biosecurity, and to compare perceptions among producer-veterinarian pairs. Questionnaires were administered to 106 producers from Quebec and their veterinarians (n = 82), and the answers of the producer-veterinarian pairs were compared. While most veterinarians reported it was easy to discuss biosecurity with their clients, most veterinarians and producers did not report discussing biosecurity. Moreover, when producers or veterinarians reported discussing biosecurity topics, there was no agreement amongst pairs. Veterinarians also misjudged how their clients perceived the importance and usefulness of biosecurity. Finally, veterinarians reported they had the knowledge and opportunity to assess and discuss biosecurity on dairy farms but lacked skills for evaluating farms and communicating their knowledge.


Différences entre les producteurs et les vétérinaires en matière de biosécurité dans les fermes laitières du Québec. Dans le cadre du programme à la ferme ProAction visant à mettre en oeuvre les exigences nationales de biosécurité dans les fermes laitières, les vétérinaires canadiens sont appelés à effectuer l'évaluation des risques reliés à la biosécurité. L'objectif de cette étude était, par conséquent, de comprendre la perception qu'ont les vétérinaires de la biosécurité et de comparer cette perception entre les paires producteurs-vétérinaires. Des questionnaires ont été administrés à 106 producteurs québécois et à leurs vétérinaires (n = 82). Les réponses des paires producteurs-vétérinaires ont été comparées. Alors que la plupart des vétérinaires ont déclaré qu'il était facile de discuter de biosécurité avec leurs clients, la plupart des vétérinaires et des producteurs n'ont pas déclaré en avoir discuté dans l'année précédant l'étude. De plus, lorsque les producteurs ou les vétérinaires ont rapporté avoir discuté de sujets liés à la biosécurité, il n'y avait pas d'accord entre les paires. Les vétérinaires ont également mal évalué la façon dont leurs clients percevaient l'importance et l'utilité des mesures de biosécurité. Enfin, les vétérinaires ont indiqué qu'ils avaient les connaissances et la possibilité d'évaluer et de discuter de la biosécurité dans les exploitations laitières, mais manquaient de compétences pour évaluer les exploitations et communiquer leurs connaissances.(Traduit par Dr José Denis-Robichaud).


Subject(s)
Veterinarians , Animal Husbandry , Animals , Canada , Dairying , Farms , Humans , Quebec , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL